WeVote
Log In

Bill

Bill

SB 142

An Act relating to municipal and state group health insurance plans and policies, including self-insured plans and policies, and the administration and management of pharmacy benefits; and providing for an effective date.

34th Legislature (2025-2026) Introduced by Cathy Giessel

Alaska SB 142 establishes state oversight of pharmacy benefit management in municipal and state employee health insurance plans to regulate drug coverage and administration practices.

(S) REFERRED TO LABOR & COMMERCE
#insurance #licensing #medicalcare #municipalities #occupations&professions #pharmacists #publicemployees #publicofficers
0
WeVote Research Nonpartisan
Bill Summary · SB 142

Legislative bill overview

SB 142 modifies how Alaska municipalities and the state manage group health insurance plans, particularly focusing on pharmacy benefit administration in both fully-insured and self-insured plans. The bill grants regulatory authority over pharmacy benefit management practices within these public employee health plans. This legislation directly impacts how prescription drug benefits are administered for state employees and municipal workers across Alaska.

Why is this important

Pharmacy benefit managers (PBMs) significantly influence drug costs and access for insured populations. By establishing state oversight of PBM practices in public health plans, the bill could affect prescription drug affordability and coverage for tens of thousands of state and municipal employees and their families. The outcome may serve as a model for how Alaska regulates these intermediaries that currently operate with minimal state-level scrutiny in the public sector.

Potential points of contention

  • PBM industry opposition: Pharmacy benefit managers may resist increased regulatory oversight, arguing it adds administrative burden and could increase costs for insurers
  • Scope ambiguity: The bill's language regarding which specific PBM practices are regulated and how remains unclear from the title alone; the actual regulatory framework could significantly impact stakeholders differently
  • Cost implications: Whether enhanced regulation reduces prescription drug costs or merely shifts expenses between plans, employees, and insurers is contested and depends on final implementation details

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.